Even if both L388R and E392K mutations give rise to pseudohypoparathyroidism, successfully developing a potential ligand for restoring cAMP production upon PTH1R stimulation could be highly mutation-dependent. The gene discussed is PTH1R; the disease is pseudohypoparathyroidism.